Jonsson Comprehensive Cancer Center
🇺🇸United States
Autologous Dendritic Cells in Treating Patients With Metastatic Kidney Cancer
Phase 1
Completed
- Conditions
- Clear Cell Renal Cell CarcinomaStage IV Renal Cell CancerRecurrent Renal Cell Cancer
- Interventions
- Biological: AdGMCAIX-transduced autologous dendritic cellsBiological: therapeutic autologous dendritic cellsOther: laboratory biomarker analysis
- First Posted Date
- 2013-04-09
- Last Posted Date
- 2021-08-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 12
- Registration Number
- NCT01826877
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Not Applicable
Completed
- Conditions
- GlioblastomaGlioma
- Interventions
- Radiation: FDOPA PET/CT
- First Posted Date
- 2013-03-19
- Last Posted Date
- 2020-07-27
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 37
- Registration Number
- NCT01813877
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Squamous Cell Lung CancerRecurrent Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
- Interventions
- Other: pharmacological studyOther: laboratory biomarker analysis
- First Posted Date
- 2013-02-06
- Last Posted Date
- 2020-09-03
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 13
- Registration Number
- NCT01784640
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Phase 1b/2 Trial Using Lapatinib, Everolimus and Capecitabine for Treatment of HER-2 Positive Breast Cancer With CNS Metastasis
Phase 1
Completed
- Conditions
- HER2-positive Breast CancerCentral Nervous System MetastasesMale Breast CancerStage IV Breast CancerRecurrent Breast Cancer
- Interventions
- First Posted Date
- 2013-02-05
- Last Posted Date
- 2019-11-12
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT01783756
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
Phase 2
Active, not recruiting
- Conditions
- Malignant Neoplasm
- Interventions
- Other: laboratory biomarker analysisBiological: NY-ESO-1 reactive TCR retroviral vector transduced autologous PBLBiological: dendritic cell vaccine therapyRadiation: fludeoxyglucose F 18Procedure: positron emission tomography
- First Posted Date
- 2012-10-02
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 6
- Registration Number
- NCT01697527
- Locations
- 🇺🇸
University of California at Los Angeles (UCLA ), Los Angeles, California, United States
Exemestane, Pemetrexed Disodium, and Carboplatin in Treating Post-Menopausal Women With Stage IV Non-Small Cell Lung Cancer
Phase 1
Completed
- Conditions
- Stage IV Non-small Cell Lung Cancer
- Interventions
- Other: laboratory biomarker analysisOther: pharmacological studyOther: questionnaire administrationProcedure: quality-of-life assessment
- First Posted Date
- 2012-08-14
- Last Posted Date
- 2019-05-07
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 8
- Registration Number
- NCT01664754
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Vaccine for Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
Phase 2
Completed
- Conditions
- Adult Diffuse AstrocytomaRecurrent Adult Brain TumorAdult OligoastrocytomaAdult Mixed GliomaAdult Oligodendroglioma
- Interventions
- Biological: tumor lysate-pulsed autologous dendritic cell vaccineOther: laboratory biomarker analysis
- First Posted Date
- 2012-07-09
- Last Posted Date
- 2020-11-04
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 5
- Registration Number
- NCT01635283
- Locations
- 🇺🇸
Jonsson Comprehensive Cancer Center, Los Angeles, California, United States
Study of Survivorship Care Plans and Outcomes in Underserved Breast Cancer Survivors
Not Applicable
Completed
- Conditions
- Breast Cancer
- Interventions
- Other: Survivorship Care Plan
- First Posted Date
- 2012-06-25
- Last Posted Date
- 2016-08-01
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 500
- Registration Number
- NCT01627366
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
Phase 2
Completed
- Conditions
- Adult Primary Hepatocellular CarcinomaLocalized Unresectable Adult Primary Liver CancerLocalized Resectable Adult Primary Liver CancerRecurrent Adult Primary Liver Cancer
- Interventions
- First Posted Date
- 2012-06-20
- Last Posted Date
- 2023-12-14
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT01624285
- Locations
- 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States
🇺🇸Lombardi Comprehensive Cancer Center at Georgetown University, Washington, District of Columbia, United States
🇺🇸Ochsner Clinic Foundation, New Orleans, Louisiana, United States
Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme
Phase 2
Completed
- Conditions
- Newly Diagnosed Glioblastoma Multiforme
- Interventions
- Other: Lapatinib/Temozolomide/radiation
- First Posted Date
- 2012-05-04
- Last Posted Date
- 2024-05-16
- Lead Sponsor
- Jonsson Comprehensive Cancer Center
- Target Recruit Count
- 50
- Registration Number
- NCT01591577
- Locations
- 🇺🇸
UCLA, Los Angeles, California, United States
© Copyright 2025. All Rights Reserved by MedPath